Ad
related to: current news update in india coronavirus vaccine information sheet hpv live
Search results
Results From The WOW.Com Content Network
On 20 August 2021, India granted emergency authorization to Zydus Cadila's vaccine ZyCoV-D, the world's first DNA plasmid-based COVID-19 vaccine, for patients 12 and older. India granted emergency use approval to the world's first DNA based COVID-19 vaccine, manufactured by for adults and children aged 12 years and above. The vaccine is ...
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry Research Assistance Council. It is approved for emergency use in India.
CoWIN (Covid Vaccine Intelligence Network) is an Indian government web portal for COVID-19 vaccination registration, owned and operated by India's Ministry of Health and Family Welfare. It displays booking slots of COVID-19 vaccine available in the nearby areas and can be booked on the website.
Foreign tourists visiting India contribute significantly to India's economy. [17] People who visit India from countries with different diseases may not have vaccines to protect against infections in India. [17] When tourists do get an infection in India, often that infection could have been prevented with a vaccine. [17] [18]
The Centers for Disease Control and Prevention (CDC) currently recommends children from ages 11 to 12 receive two doses of the HPV vaccine, given six to 12 months apart, although children can get ...
In August, China's National Intellectual Property Administration issued the country's first COVID-19 vaccine patent to CanSino. [34] On 16 May 2020, Canadian Prime Minister Justin Trudeau announced Health Canada had approved Phase II trials to be conducted by the Canadian Center for Vaccinology (CCfV) on the COVID-19 vaccine produced by CanSino.
In May 2020, Indian Council of Medical Research's (ICMR's) National Institute of Virology approved and provided the virus strains for developing an Indian COVID-19 vaccine. [ 25 ] [ 26 ] In June 2020, the company received permission to conduct Phase I and Phase II human trials of a developmental COVID-19 vaccine codenamed BBV152 , from the ...
Aarogya Setu (translation from Sanskrit: the bridge to health) is an Indian COVID-19 "contact tracing, syndromic mapping and self-assessment" digital service, primarily a mobile app, developed by the National Informatics Centre under the Ministry of Electronics and Information Technology (MeitY). The app reached more than 100 million installs ...